375 related articles for article (PubMed ID: 31407637)
1. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
[No Abstract] [Full Text] [Related]
2. Survival benefit of active surveillance for papillary thyroid carcinoma: a propensity score matching analysis based on SEER database.
Bi J; Lyu PF; Wang Y; Zhang H
Front Oncol; 2023; 13():1185650. PubMed ID: 37361590
[TBL] [Abstract][Full Text] [Related]
3. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
4. Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?
Griffin A; Brito JP; Bahl M; Hoang JK
Thyroid; 2017 Apr; 27(4):518-523. PubMed ID: 28125944
[TBL] [Abstract][Full Text] [Related]
5. Observation versus thyroidectomy for papillary thyroid microcarcinoma in the elderly.
Megwalu UC
J Laryngol Otol; 2017 Feb; 131(2):173-176. PubMed ID: 28007045
[TBL] [Abstract][Full Text] [Related]
6. NONOPERATIVE MANAGEMENT OF DIFFERENTIATED THYROID CANCER IN CALIFORNIA: A POPULATION-LEVEL ANALYSIS OF 29,978 PATIENTS.
Kuo EJ; Wu JX; Li N; Zanocco KA; Yeh MW; Livhits MJ
Endocr Pract; 2017 Oct; 23(10):1262-1269. PubMed ID: 28816539
[TBL] [Abstract][Full Text] [Related]
7. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.
Tuttle RM; Fagin JA; Minkowitz G; Wong RJ; Roman B; Patel S; Untch B; Ganly I; Shaha AR; Shah JP; Pace M; Li D; Bach A; Lin O; Whiting A; Ghossein R; Landa I; Sabra M; Boucai L; Fish S; Morris LGT
JAMA Otolaryngol Head Neck Surg; 2017 Oct; 143(10):1015-1020. PubMed ID: 28859191
[TBL] [Abstract][Full Text] [Related]
8. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
[TBL] [Abstract][Full Text] [Related]
9. Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage.
Zambeli-Ljepović A; Wang F; Dinan MA; Hyslop T; Roman SA; Sosa JA; Scheri RP
J Surg Res; 2019 Nov; 243():189-197. PubMed ID: 31185435
[TBL] [Abstract][Full Text] [Related]
10. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
Sakai T; Sugitani I; Ebina A; Fukuoka O; Toda K; Mitani H; Yamada K
Thyroid; 2019 Jan; 29(1):59-63. PubMed ID: 30560718
[TBL] [Abstract][Full Text] [Related]
11. Association of adjuvant radioactive iodine therapy with survival in node-positive papillary thyroid cancer.
Sun Y; Gong J; Guo B; Shang J; Cheng Y; Xu H
Oral Oncol; 2018 Dec; 87():152-157. PubMed ID: 30527231
[TBL] [Abstract][Full Text] [Related]
12. Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.
Holoubek SA; MacKinney EC; Khokar AM; Kuchta KM; Winchester DJ; Prinz RA; Moo-Young TA
Surgery; 2022 Jan; 171(1):203-211. PubMed ID: 34384604
[TBL] [Abstract][Full Text] [Related]
13. Should small papillary thyroid cancer be observed? A population-based study.
Nilubol N; Kebebew E
Cancer; 2015 Apr; 121(7):1017-24. PubMed ID: 25425528
[TBL] [Abstract][Full Text] [Related]
14. Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years.
James BC; Timsina L; Graham R; Angelos P; Haggstrom DA
Surgery; 2019 Jul; 166(1):41-47. PubMed ID: 30904172
[TBL] [Abstract][Full Text] [Related]
15. Active surveillance of low-risk papillary thyroid cancer: A meta-analysis.
Saravana-Bawan B; Bajwa A; Paterson J; McMullen T
Surgery; 2020 Jan; 167(1):46-55. PubMed ID: 31526581
[TBL] [Abstract][Full Text] [Related]
16. Overall survival is improved with total thyroidectomy and radiation for male patients and patients older than 55 with T2N0M0 Stage 1 classic papillary thyroid cancer.
MacKinney EC; Kuchta KM; Winchester DJ; Khokar AM; Holoubek SA; Moo-Young TA; Prinz RA
Surgery; 2022 Jan; 171(1):197-202. PubMed ID: 34666913
[TBL] [Abstract][Full Text] [Related]
17. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
18. Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis.
Liu C; Chen T; Zeng W; Wang S; Xiong Y; Liu Z; Huang T
Sci Rep; 2017 Sep; 7(1):11412. PubMed ID: 28900207
[TBL] [Abstract][Full Text] [Related]
19. Paradoxes in thyroid carcinoma treatment: analysis of the SEER database 2010-2013.
Zhou P; Tian S; Li J; Zhao Y; Liu W; Zhang Y; Hu Z
Oncotarget; 2017 Jan; 8(1):345-353. PubMed ID: 27861148
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems.
Adam MA; Thomas S; Hyslop T; Scheri RP; Roman SA; Sosa JA
J Clin Oncol; 2016 Dec; 34(36):4415-4420. PubMed ID: 27998233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
